← Back to Search

Cognitive and Physical Training for COPD

N/A

Recruiting

Led By Dmitry Rozenberg, MD PhD

Research Sponsored by University Health Network, Toronto

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Clinical and spirometric diagnosis of COPD (FEV1 30-80%)

Adult participants (≥ 50 years of age)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up over the intervention period (8 weeks) and one year prior to study enrollment

Awards & highlights

No Placebo-Only Group

Summary

This trial will test the feasibility of an 8-week home-based cognitive-physical training program for COPD patients, as well as the efficacy of the program in improving physical and cognitive performance.

Who is the study for?

This trial is for adults over 50 with COPD, which is a lung condition that makes it hard to breathe. They should be able to move on their own and have internet access. It's not for people outside this group or those who can't safely do the exercises.

What is being tested?

The study tests an 8-week home program combining brain games and physical exercise to see if it helps improve thinking, moving, daily activities, and life quality in COPD patients compared to just physical exercise.

What are the potential side effects?

Since the interventions involve cognitive games and physical exercises tailored for COPD patients, side effects are minimal but may include muscle soreness or fatigue from the exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with COPD and my lung function is between 30-80%.

Select...

I am 50 years old or older.

Select...

I can move around on my own safely, with or without help like a cane.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ over the intervention period (8 weeks) and one year prior to study enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~over the intervention period (8 weeks) and one year prior to study enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and over the intervention period (8 weeks) and one year prior to study enrollment for reporting.